By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

A hybrid experimental and machine learning framework for designing and predicting compressive strength of ultra-high-performance concrete

Science Briefing

Science Briefing

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - Today’s Clinical Medicine Science Briefing | April 23rd 2026, 9:00:12 am

Medicine

Today’s Clinical Medicine Science Briefing | April 23rd 2026, 9:00:12 am

Last updated: April 23, 2026 7:32 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

Key Highlights

•
A study of over 18,000 crashes found that children in neighborhoods with the lowest “Child Opportunity Index” had a 35% higher incidence of pedestrian and bicyclist crashes and were over 2.8 times more likely to be fatally injured compared to children in the highest-opportunity areas. This highlights a major health equity issue, showing that a child’s risk of severe injury is strongly linked to their neighborhood’s socioeconomic resources.
Source →

•
A new analysis of the DART trial provides final results, showing that a combination of two immunotherapy drugs (CTLA-4 and PD-1 inhibitors) produced meaningful treatment responses across 53 different types of rare, hard-to-treat cancers. This is a significant step forward, offering a potential new treatment avenue for patients with rare cancers who have run out of other options.
Source →

•
Researchers have developed new, easier-to-make versions of iboga plant compounds that show improved pain-relieving and anxiety-reducing effects in preclinical studies, while also protecting nerve cells. This work could lead to safer, more effective non-opioid treatments for pain and anxiety disorders.
Source →


Stay curious. Stay informed — with
Science Briefing.

Always double check the original article for accuracy.


Reset My Briefings

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Today’s Neurology Science Briefing | April 23rd 2026, 9:00:12 am
Next Article Today’s Immunology Science Briefing | April 23rd 2026, 9:00:12 am
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

The Shifting Landscape of Ovarian Cancer Risk Across Generations

Today’s Diabetes Science Briefing | March 16th 2026, 1:00:12 pm

A Salivary Link: How Dry Mouth May Dampen the Mind

The MENA Gap: Why Clinical Trials for Chronic Inflammatory Diseases Are Falling Short

Unlocking the Inflammatory Code: How a Key Developmental Pathway Drives Microglial Activation

Science Briefing

The Gut-Brain-Axis of Inflammation: Serotonin’s Surprising Role in Endometriosis

Kalp Yetmezliği ve Diyabet: Yeni Bir Tedavinin Karmaşık Etkileşimi

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Energy
  • Gastroenterology
  • Surgery
  • Uncategorized
  • Chemistry
  • Natural Language Processing
  • Engineering

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?